Experts debate over future Parkinson’s disease trial involving growth factors

Experts debate over future Parkinson’s disease trial involving growth factors

Experts debate over future Parkinson’s disease trial involving growth factors

Growth factors such as glial cell line-derived neurotrophic factor (GDNF) were initially thought to be exciting new treatments for Parkinson's disease (PD), but trials have been disappointing.